Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Respiratory Pathogen Testing Kits Market Outlook (2023 to 2033)

As per the latest market research conducted by FMI, the global respiratory pathogen testing kits market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 4,083.1 million. By 2033, the valuation is expected to be worth US$ 7,136.8 million.

The most prevalent illnesses that infect people are respiratory tract infections. It has been linked to less serious lower respiratory tract infections (LRTIs), such as pneumonia and bronchitis, as well as self-limiting upper respiratory tract infections (URTIs), like the common cold. Lower respiratory tract infections (LRTIs) have a considerable impact on disease burden and are a leading cause of hospitalization, morbidity, and death in kids and seniors.

The viral respiratory incidents per year in developed countries have been estimated between 5 and 10 in children under the age of six compared to 3 to 6 in those over this age, and acute respiratory infection continues to account for 35% to 45% of hospitalized patients, according to data from the National Institutes of Health. Thus, increasing the respiratory pathogen testing demand to a great extent.

Crucial Growth Factors of the Respiratory Pathogen Testing Kits Market:

  • The global market for respiratory pathogen testing kits is expanding as a result of factors like rising chronic illness prevalence, increasing pathogen testing and preventative healthcare awareness, growing manufacturer promotional efforts, and rising public knowledge of respiratory pathogen test equipment. Thus, it is likely to drive the growth of the respiratory pathogen test equipment market in the coming years.
  • The availability of enhanced healthcare infrastructure in undeveloped and emerging economies is likely to create profitable demand for respiratory pathogen test devices and drive the growth of the respiratory pathogen test devices market in the future.
  • The COVID-19 pandemic had a favorable effect on the market for respiratory pathogen testing kits worldwide. The pandemic increased the need for the respiratory pathogen panel test market to map COVID-19 antibodies for COVID-19 infection and detect molecular tests for the disease.
  • Due to a boost in growth for the respiratory pathogen test equipment market, the market for these kits saw a modest increase during the lockdown. As the demand for pathogen test equipment increased to advance diagnostic systems during COVID-19, this has enabled the respiratory pathogen testing kits sector to develop substantially.
  • Diagnostic tests have undergone tremendous technological advancement in recent years, which has improved the reliability and accuracy of the identification of respiratory pathogens. Globally, respiratory pathogen testing demand is increasing as a result of this.
Attributes Value
Respiratory Pathogen Testing Kits Value (2022) US$ 3,852.9 million
Respiratory Pathogen Testing Kits Market Expected Value (2023) US$ 4,083.1 million
Respiratory Pathogen Testing Kits Market Forecast Value (2033) US$ 7,136.8 million
Respiratory Pathogen Testing Kits Market Expected CAGR (2023 to 2033) 5.7%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Trends of the Respiratory Pathogen Testing Kits Market

  • A massive influx of respiratory illness incidences generates a market opportunity for respiratory pathogen testing kits, which is driven by growth and innovation in the diagnostic and biotech sector.
  • Given the increasing preference of consumers for online buying over conventional purchase methods, e-commerce has emerged as a crucial tool for small and sizable enterprises worldwide. This is said to promote the expansion of the market for respiratory pathogen testing kits.

How has the Market Progressed till June 2022?

Particulars Details
H1, 2021 5.86%
H1, 2022 Projected 6.06%
H1, 2022 Outlook 5.96%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 10 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (+) 10 ↑

According to Future Market Insights' analysis, the global respiratory pathogen testing kits market expects to increase by 10 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during the H1-2022 outlook period showed a dip of 10 BPS.

Given the constraints of quick testing, which can't assess widespread coinfection detection, the market for respiratory pathogen testing kits sees a fall in BPS values. Testing kits also have drawbacks, including a lengthy turnaround time, labor-intensive procedures, and low sensitivity.

However, due to the high specificity of RP panel tests for many viruses and bacteria in the respiratory tract, the market is likely to witness an upswing in terms of growth with the introduction of RP tests.

The market is subject to changes as per the regulatory norms and product adoption rates, concerning the macro and industry dynamics. The key developments in the market include the development of PCR-based diagnostic test panels to detect and differentiate common respiratory pathogens simultaneously.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Respiratory Pathogen Testing Kit Demand Analysis (2018 to 2022) Vs Market Outlook (2023 to 2033)

Sales of respiratory pathogen testing kits expanded at a rapid CAGR of 9.8% from 2018 to 2022.

A respiratory pathogen testing kit can be used to detect respiratory infections by analyzing blood, fluids, or samples from the affected area of the body.

Respiratory pathogen testing kits can identify the most common illnesses' genetic material (RNA/DNA). It can recognize a variety of pathogenic bacteria and discover germs that conventional techniques, like blood cultures, can lack. Several test kits can identify specific strains or subgroups of microorganisms.

Uncontrolled ingestion of different gases, such as sulfur dioxide and carbon monoxide, can obstruct the respiratory tract. Many bacterial, fungal, and viral illnesses of the respiratory system can be identified with respiratory pathogen testing kits.

Lateral flow tests, also referred to as immunochromatographic assays, reverse transcription-polymerase chain reaction (RT-PCR) tests, direct fluorescent antibody (DFA) tests, solid-phase assays, agglutination assays, and flow-through assays are among the various types of respiratory pathogen testing.

Chronic Obstructive Pulmonary Disease (COPD) is a lung disease that causes a decline in airflow over time. As per the WHO, low and middle-income nations account for 90% of COPD deaths.

Over 251 million instances of chronic obstructive pulmonary disease were reported globally, according to the Global Burden of Disease survey. In the upcoming years, it is anticipated to increase as the global population ages and people's lifestyles change. The market for respiratory pathogen testing kits is growing as early detection and treatment become more important.

The respiratory pathogen testing kits market is predicted to record a significant CAGR of 5.7% from 2023 to 2033 and is expected to reach a valuation of US$ 7,136.8 million by 2033.

Comparative Analysis of Adjacent Markets

Respiratory Pathogen Testing Kits Market:

Differentiating Aspects Respiratory Pathogen Testing Kits Market
Anticipated CAGR (2023 to 2033) 5.7%
Market Valuation (2023) US$ 4,083.1 million
Growth Factors Rising chronic illness prevalence and increasing pathogen testing and preventative healthcare awareness.
Future Opportunities The market for respiratory pathogen testing kits is driven by a significant increase in respiratory illness incidences.
Market Trends Future market demand is likely to be profitable since developing and emerging economies have access to improved healthcare facilities.

Blood Transfusion Devices Market:

Differentiating Aspects Blood Transfusion Devices Market
Anticipated CAGR (2023 to 2033) 5.9%
Market Valuation (2023) US$ 4,975.77 million
Growth Factors Blood-related illnesses and chronic renal disease are becoming more common.
Future Opportunities Issues such as a strict regulatory framework and high costs associated with the treatment of blood and its components are likely to drive market expansion.
Market Trends The transition from manual testing and instrumentation to semi-automated and fully automated equipment is intensifying with the development of novel molecular platforms.

Blood Transfusion Market:

Differentiating Aspects Blood Transfusion Market
Anticipated CAGR (2023 to 2033) 7%
Market Valuation (2023) US$ 4.69 billion
Growth Factors Blood transfusion demand is predicted to rise due to an increase in anemic people who require red blood cell transfusions to treat their condition.
Future Opportunities The use of stem cell technologies to manufacture lab-grown blood cells for human transfusion is one of the advanced research procedures and is expected to create multiple opportunities.
Market Trends The emergence of cost-effective and novel technology to inactivate or minimize the risk of infection is increasing demand for a pathogen reduction system.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Which aspects are Positively Influencing Demand for Respiratory Pathogen Testing Kits?

Increased Research and Development Funding Improve Respiratory Pathogen Testing Systems Sales

Market Growth is Boosted by Increased Funding for Respiratory Diagnostics

  • Thermo Fisher acquired Mesa Biotech in February 2021 to strengthen its Life Sciences Solutions business sector. As a result of this acquisition, this segment's revenue increased by over US$ 200 million in 2021.

Rising Incidence of Chronic Diseases is Likely to Increase the Usage of Respiratory Pathogen Testing Equipment

  • The respiratory pathogen testing devices market is predicted to develop due to the increased use of imaging technologies such as computed tomography (CT) in COPD diagnosis.
  • Pulse oximeters are only one example of cutting-edge equipment that is being successfully used in outpatient COPD care. The trend of non-invasive mechanical ventilation for COPD is another factor that is anticipated to fuel market expansion.

Need for Advanced Diagnostic Testing Methods Fuelling Demand for Respiratory Pathogen Testing Kits

  • Rapid molecular tests, antigen testing, immunofluorescence assays, vital culture, and real-time polymerase chain reaction (RT-PCR) are the diagnostic techniques accessible to diagnose bacterial and viral infections in the contemporary scenario (reverse transcription-polymerase chain reaction). The ‘PathoDetect COVID-19 Qualitative PCR kit’ was created by Mylab, an Indian company.
  • According to the manufacturer, this kit uses the RT-PCR technique to identify infection within 2.5 hours (as compared to 7.5 hours taken previously). Since more diseases can be found in much less time, this factor is expected to increase demand for respiratory pathogen test kits in India and other countries in the Asia Pacific (considering the increasing incidences and population density in this region).
  • Staphylococcus Aureus, Moraxella Catarrhalis, Haemophilus Influenzae, And Streptococcus Pneumoniae are among the additional microorganisms that require effective respiratory pathogen testing kits. Apart from the methods stated above, multiplex PCR technology is being used since it provides fast and accurate respiratory pathogen detection.
  • Although several respiratory pathogen testing kits sold test for viruses and bacteria, fungi also have a part to play. There may be a rise in demand for these kits globally as a result.
  • Rapid molecular tests are a brand-new, highly accurate, and specific type of molecular diagnostic test for influenza. NATs are used for recognizing certain illnesses (Natural Antisense Transcripts). The key advantage of NATs is that they can offer data in a therapeutically relevant period and do not depend on the viability of the target microorganisms.

Strict Laws for the Mining Sector Increase the Usage of Respiratory Pathogen Testing Kits

  • Coal miners worldwide are at a high risk of developing non-malignant respiratory conditions like COPD as a result of unintentional intake of silica dust (which contains bacteria).
  • In the EU, there are around 53,000 people employed by coal power stations and 185,000 by coal mines. The EU's regulatory body also conducts routine audits of these workers, which boosts demand for respiratory pathogen testing kits.
  • There are mining laws and restrictions in places like Australia to ensure the security of coal miners. Coal mining companies are required to have respiratory pathogen testing kits on site as part of environmental regulations.
  • Likewise, government safety laws oversee high-risk professions, including coal mining. Some workplaces use respiratory pathogen testing kits as a consequence to report the health status of their employees. It is anticipated that this ongoing need is expected to keep the market for respiratory pathogen testing kits growing.

What aspects are Likely to Limit the Market Expansion for Respiratory Pathogen Testing Kits?

High Product Costs and a Lack of Consumer Awareness are Expected to Restrain the Market's Growth for Respiratory Pathogen Testing Kits.

  • The high cost of operating molecular processes (especially by private laboratories) may restrict market expansion in emerging nations, even though molecular diagnostic methods have grown to be a significant component of life science research.
  • Together with the development of technological and procedural advances in biotechnology, testing costs have increased.
  • The inbound expenditures are borne by the patients. Global players have to therefore stay alert for chances to reduce costs.
  • Primary commercial obstacles include a lack of awareness and the occurrence of a sizable underdiagnosed and undertreated population.

Which Regional Markets are Likely to be Profitable for Respiratory Pathogen Testing Kit Providers?

Due to the Rising Prevalence of Respiratory Disorders, North America is likely to have a Significant Market Share

The United States market is projected to be the lucrative market for respiratory pathogen testing kits. The market is anticipated to record a CAGR of 6.6% and is anticipated to continue on this path in the years to come. A sedentary lifestyle, along with COVID-19 and other existing viral, bacterial, and fungal diseases, is driving the market in this region.

Crucial Revenue Stimulator for Asia Pacific

In response to the increased cases of COVID-19, the respiratory pathogen testing kit market in the Asia Pacific is gaining momentum. Air pollution is another market-stimulating factor. More than 20 of the most polluting nations in the world are located in the Asia Pacific, according to IQAir. Sales of respiratory pathogen testing kits are rising as a result of the congestion of the respiratory tract brought on by uncontrolled ingestion of carbon monoxide and sulfur dioxide.

How is China's Market for Respiratory Pathogen Testing Kits Expanding?

The top genomics company in the world, BGI Group, has partnered with China's military on projects ranging from mass testing for respiratory viruses to brain science, according to a Reuters review of research, patent filings, and other publications.

According to an analysis of more than 40 publicly available documents and research articles in Chinese and English, BGI has connections to the People's Liberation Army (PLA), including research with China's top military supercomputing professionals. China was the location where the COVID-19 pandemic started, and it swiftly spread throughout the world. Since that time, the diagnostic industry has expanded rapidly.

Growth Outlook of Country-wise Insights

Countries United States
CAGR (2018 to 2022) 10.6%
CAGR (2023 to 2033) 6.6%
Valuation (2033) US$ 2,438.4 million
Countries United Kingdom
CAGR (2018 to 2022) 7.6%
CAGR (2023 to 2033) 6.0%
Valuation (2033) US$ 379.2 million
Countries China
CAGR (2018 to 2022) 10.1%
CAGR (2023 to 2033) 6.3%
Valuation (2033) US$ 585.7 million
Countries Germany
CAGR (2018 to 2022) 10.3%
CAGR (2023 to 2033) 6.0%
Valuation (2033) US$ 552.6 million

Category-wise Analysis

Which Technology Enables the Market for Respiratory Pathogen Testing Kits to Grow the Most?

A type of viral diagnostic test known as a Nucleic Acid Amplification Test, or NAAT, is used to identify SARS-CoV-2, the virus that causes COVID-19. Genetic material detectors are NAATs (nucleic acids). The RNA (ribonucleic acid) sequences that make up the virus' genetic information are precisely identified by SARS-CoV-2 NAATs.

NAATs are utilized for SARS-CoV-2 test samples from the upper or lower respiratory tracts. The type of specimen used for SARS-CoV-2 testing depends on both the test being run and the manufacturer's instructions.

The advancement of nucleic acid amplification testing technology is being fueled by the rising incidence of contagious diseases, the growing demand for better diagnostic tools, and increased funding for the creation of novel biotechnological diagnostic techniques. Now, nucleic acid amplification testing is anticipated to hold a 44.6% market share overall.

Competitive Background

The presence of several manufacturers and key market players operating at the worldwide level defines the respiratory pathogen testing kits market. Leading respiratory pathogen testing equipment manufacturers are concentrating their efforts on developing unique testing kits that are expected to aid in obtaining results quickly. They are investing heavily to get a competitive advantage over one another.

Significant Key Players in the Market:

  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Hoffmann-La Roche Ltd.
  • bioMérieux Inc.
  • Altona Diagnostics
  • MyLab

Recent Development:

  • In November 2021, Philips added more powerful imaging tools and features to its ultrasound solution for Radiology, improving workflow effectiveness and diagnostic certainty.

Respiratory Pathogen Testing Kits Industry Report Scope

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value, Units for Volume
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • The Middle East & Africa (MEA)
Key Countries Covered
  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Türkiye
  • South Africa
  • and GCC Countries
Key Market Segments Covered
  • Product
  • Infection/Symptom
  • Technology
  • End User
  • Region
Key Companies Profiled
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Danaher Corporation
  • Becton, Dickinson, and Company
  • Hoffmann-La Roche Ltd.
  • bioMérieux Inc.
  • Altona Diagnostics
  • MyLab
Pricing Available upon Request

Key Segments of Respiratory Pathogen Testing Kits Industry Survey

Respiratory Pathogen Testing Kits Market by Product:

  • RT PCR Kits
  • DFA Kits
  • ELISA Kits
  • Others

Respiratory Pathogen Testing Kits Market by Infection/Symptom:

  • Matrix
  • Enterovirus Infection
  • Human Coronavirus Infection
  • Influenza Virus Infection
  • Respiratory Syncytial Virus Infection
  • Rhinovirus Infection
  • Pneumonia

Respiratory Pathogen Testing Kits Market by Technology:

  • NAAT (Nucleic Acid Amplification)
  • Immunoassays
  • Others

Respiratory Pathogen Testing Kits Market by End User:

  • Hospitals
  • Diagnostic Centers
  • Specialty Clinics

Respiratory Pathogen Testing Kits Market by Region:

  • North America Respiratory Pathogen Testing Kits Market
  • Latin America Respiratory Pathogen Testing Kits Market
  • Europe Respiratory Pathogen Testing Kits Market
  • East Asia Respiratory Pathogen Testing Kits Market
  • South Asia & Pacific Respiratory Pathogen Testing Kits Market
  • The Middle East & Africa Respiratory Pathogen Testing Kits Market

Frequently Asked Questions

How Big Will the Respiratory Pathogen Testing Kits Market by 2033?

The market is estimated to reach US$ 7,136.8 million by 2033.

What is the Growth Potential of the Respiratory Pathogen Testing Kits Market?

The market is expected to record a growth of 5.7% through 2033.

What Factors are Yeilding Market Expansion?

Surging rate of chronic diseases and increasing funding for respiratory diagnostics.

Which is the Top Trend in the Respiratory Pathogen Testing Kits Market?

Growing awareness about preventative healthcare.

What Opportunities Await for the Market Players?

Surging incidence of respiratory illness may create opportunity for market players.

Table of Content

1. Executive Summary | Respiratory Pathogen Testing Kits Market 

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. RT PCR Kits

        5.3.2. DFA Kits

        5.3.3. ELISA Kits

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Infection

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Infection, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Infection, 2023 to 2033

        6.3.1. Enterovirus Infection

        6.3.2. Human Coronavirus Infection

        6.3.3. Influenza Virus Infection

        6.3.4. Respiratory Syncytial Virus Infection

        6.3.5. Rhinovirus Infection

    6.4. Y-o-Y Growth Trend Analysis By Infection, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Infection, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Diagnostic Centres

        7.3.3. Speciality Clinics

    7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Infection

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Infection

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Infection

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Infection

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Product

        11.2.3. By Infection

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Infection

        11.3.4. By End User

    11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Product

        12.2.3. By Infection

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Infection

        12.3.4. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product

        13.2.3. By Infection

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Infection

        13.3.4. By End User

    13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Product

        14.2.3. By Infection

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Infection

        14.3.4. By End User

    14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Infection

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Infection

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product

            16.1.2.2. By Infection

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product

            16.2.2.2. By Infection

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product

            16.3.2.2. By Infection

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product

            16.4.2.2. By Infection

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product

            16.5.2.2. By Infection

            16.5.2.3. By End User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product

            16.6.2.2. By Infection

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product

            16.7.2.2. By Infection

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product

            16.8.2.2. By Infection

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product

            16.9.2.2. By Infection

            16.9.2.3. By End User

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product

            16.10.2.2. By Infection

            16.10.2.3. By End User

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product

            16.11.2.2. By Infection

            16.11.2.3. By End User

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product

            16.12.2.2. By Infection

            16.12.2.3. By End User

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product

            16.13.2.2. By Infection

            16.13.2.3. By End User

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product

            16.14.2.2. By Infection

            16.14.2.3. By End User

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product

            16.15.2.2. By Infection

            16.15.2.3. By End User

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product

            16.16.2.2. By Infection

            16.16.2.3. By End User

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product

            16.17.2.2. By Infection

            16.17.2.3. By End User

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product

            16.18.2.2. By Infection

            16.18.2.3. By End User

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product

            16.19.2.2. By Infection

            16.19.2.3. By End User

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product

            16.20.2.2. By Infection

            16.20.2.3. By End User

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product

            16.21.2.2. By Infection

            16.21.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Infection

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Thermo Fisher Scientific

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Abbott Laboratories

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Danaher Corporation

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Becton, Dickinson and Company

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Hoffmann-La Roche Ltd.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. bioMérieux Inc.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Altona Diagnostics

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Mylab Discovery Solutions Pvt Ltd.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Siemens Healthineers AG

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Sysmex Corporation

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Infection, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Infection, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Infection, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Infection, 2018 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: South Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 19: South Asia Market Value (US$ Million) Forecast by Infection, 2018 to 2033

Table 20: South Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: East Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 23: East Asia Market Value (US$ Million) Forecast by Infection, 2018 to 2033

Table 24: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: Oceania Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 27: Oceania Market Value (US$ Million) Forecast by Infection, 2018 to 2033

Table 28: Oceania Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 30: MEA Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 31: MEA Market Value (US$ Million) Forecast by Infection, 2018 to 2033

Table 32: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Infection, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Infection, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Infection, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Infection, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 17: Global Market Attractiveness by Product, 2023 to 2033

Figure 18: Global Market Attractiveness by Infection, 2023 to 2033

Figure 19: Global Market Attractiveness by End User, 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Product, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Infection, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End User, 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Infection, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Infection, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Infection, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 37: North America Market Attractiveness by Product, 2023 to 2033

Figure 38: North America Market Attractiveness by Infection, 2023 to 2033

Figure 39: North America Market Attractiveness by End User, 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Product, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Infection, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End User, 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Infection, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Infection, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Infection, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 57: Latin America Market Attractiveness by Product, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Infection, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Product, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Infection, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Infection, 2018 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Infection, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Infection, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 77: Europe Market Attractiveness by Product, 2023 to 2033

Figure 78: Europe Market Attractiveness by Infection, 2023 to 2033

Figure 79: Europe Market Attractiveness by End User, 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: South Asia Market Value (US$ Million) by Product, 2023 to 2033

Figure 82: South Asia Market Value (US$ Million) by Infection, 2023 to 2033

Figure 83: South Asia Market Value (US$ Million) by End User, 2023 to 2033

Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: South Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 89: South Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 91: South Asia Market Value (US$ Million) Analysis by Infection, 2018 to 2033

Figure 92: South Asia Market Value Share (%) and BPS Analysis by Infection, 2023 to 2033

Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Infection, 2023 to 2033

Figure 94: South Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 95: South Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 97: South Asia Market Attractiveness by Product, 2023 to 2033

Figure 98: South Asia Market Attractiveness by Infection, 2023 to 2033

Figure 99: South Asia Market Attractiveness by End User, 2023 to 2033

Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033

Figure 101: East Asia Market Value (US$ Million) by Product, 2023 to 2033

Figure 102: East Asia Market Value (US$ Million) by Infection, 2023 to 2033

Figure 103: East Asia Market Value (US$ Million) by End User, 2023 to 2033

Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: East Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 109: East Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 111: East Asia Market Value (US$ Million) Analysis by Infection, 2018 to 2033

Figure 112: East Asia Market Value Share (%) and BPS Analysis by Infection, 2023 to 2033

Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Infection, 2023 to 2033

Figure 114: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 115: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 117: East Asia Market Attractiveness by Product, 2023 to 2033

Figure 118: East Asia Market Attractiveness by Infection, 2023 to 2033

Figure 119: East Asia Market Attractiveness by End User, 2023 to 2033

Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 121: Oceania Market Value (US$ Million) by Product, 2023 to 2033

Figure 122: Oceania Market Value (US$ Million) by Infection, 2023 to 2033

Figure 123: Oceania Market Value (US$ Million) by End User, 2023 to 2033

Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: Oceania Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 131: Oceania Market Value (US$ Million) Analysis by Infection, 2018 to 2033

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Infection, 2023 to 2033

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Infection, 2023 to 2033

Figure 134: Oceania Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 135: Oceania Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 137: Oceania Market Attractiveness by Product, 2023 to 2033

Figure 138: Oceania Market Attractiveness by Infection, 2023 to 2033

Figure 139: Oceania Market Attractiveness by End User, 2023 to 2033

Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033

Figure 141: MEA Market Value (US$ Million) by Product, 2023 to 2033

Figure 142: MEA Market Value (US$ Million) by Infection, 2023 to 2033

Figure 143: MEA Market Value (US$ Million) by End User, 2023 to 2033

Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: MEA Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 149: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 151: MEA Market Value (US$ Million) Analysis by Infection, 2018 to 2033

Figure 152: MEA Market Value Share (%) and BPS Analysis by Infection, 2023 to 2033

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Infection, 2023 to 2033

Figure 154: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 157: MEA Market Attractiveness by Product, 2023 to 2033

Figure 158: MEA Market Attractiveness by Infection, 2023 to 2033

Figure 159: MEA Market Attractiveness by End User, 2023 to 2033

Figure 160: MEA Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Chiari Malformation Treatment Market

Published : March 2023

Healthcare

Carcinoid Tumor Syndrome Management Market

Published : March 2023

Explore Healthcare Insights

View Reports

Respiratory Pathogen Testing Kits Market